Found: 9
Select item for more details and to access through your institution.
Annexin A2 Promotes Glioma Cell Invasion and Tumor Progression.
- Published in:
- Journal of Neuroscience, 2011, v. 31, n. 40, p. 14346, doi. 10.1523/JNEUROSCI.3299-11.2011
- By:
- Publication type:
- Article
Setting the stage for biosimilar monoclonal antibodies.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 12, p. 1179, doi. 10.1038/nbt.2447
- By:
- Publication type:
- Article
The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.
- Published in:
- Oncologist, 2016, v. 21, n. 1, p. 102, doi. 10.1634/theoncologist.2015-0276
- By:
- Publication type:
- Article
The European Medicines Agency Review of Abiraterone for the Treatment of Metastatic Castration-Resistant Prostate Cancer in Adult Men After Docetaxel Chemotherapy and in Chemotherapy-Naïve Disease: Summary of the Scientific Assessment of the Committee...
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
The European Medicines Agency Review of Abiraterone for the Treatment of Metastatic Castration-Resistant Prostate Cancer in Adult Men After Docetaxel Chemotherapy and in Chemotherapy-Naave Disease: Summary of the Scientific Assessment of the Committee...
- Published in:
- Oncologist, 2013, v. 18, n. 9, p. 1032, doi. 10.1634/theoncologist.2013-0092
- By:
- Publication type:
- Article
European Medicines Agency Review of Ofatumumab (Arzerra®) for the Treatment of Chronic Lymphocytic Leukemia in Patients Refractory to Fludarabine and Alemtuzumab: Summary of the Scientific Assessment of the European Medicines Agency Committee for...
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
European Medicines Agency Review of Ofatumumab (Arzerra©) for the Treatment of Chronic Lymphocytic Leukemia in Patients Refractory to Fludarabine and Alemtuzumab: Summary of the Scientific Assessment of the European Medicines Agency Committee for...
- Published in:
- Oncologist, 2010, v. 15, n. 12, p. 1335, doi. 10.1634/theoncologist.2010-0255
- By:
- Publication type:
- Article
Tissue plasminogen activator and glial function.
- Published in:
- Glia, 2005, v. 49, n. 2, p. 177, doi. 10.1002/glia.20115
- By:
- Publication type:
- Article
Proteolytic Activation of Monocyte Chemoattractant Protein-1 by Plasmin Underlies Excitotoxic Neurodegeneration in Mice.
- Published in:
- Journal of Neuroscience, 2007, v. 27, n. 7, p. 1738, doi. 10.1523/JNEUROSCI.4987-06.2007
- By:
- Publication type:
- Article